Neuro-Oncology Reviews

Volume 28 Number 20
20 July 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 20, 20 July

Haddad AF, Ramesh R, Agudelo JAP, Salha C, Prakash P, Aghi SR, Trippett JS, Castro MG, Aghi MK.
Recent Advances and Future Prospects in Gene Delivery Platforms for Glioblastoma: A Review.
JAMA Neurol. 2026 Jul 13. doi: 10.1001/jamaneurol.2026.2131. PMID: 42440296˰ ˍ

Donnini F, Battaglia G, Chibbaro S, Marampon F, Minniti G, Tini P.
Tumor Treating Fields and the Glioblastoma Microenvironment: Mechanistic Convergences with Radiotherapy.
Cancers (Basel). 2026 Jun 25;18(13):2069. doi: 10.3390/cancers18132069. PMID: 42449613. ˍ

Zhang H, Wu X, Liao H, Zhang Y.
Immune niche-associated and niche-regulated plasticity in glioblastoma: state transitions, immune escape, and therapeutic vulnerabilities.
Front Immunol. 2026 Jun 26;17:1857659. doi: 10.3389/fimmu.2026.1857659. PMID: 42433345. ˍ

He Y, Song W, Li S, Guo J.
The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance.
Front Cell Dev Biol. 2026 Jul 1;14:1834106. doi: 10.3389/fcell.2026.1834106. PMID: 42459835. ˍ

Dieli C, Costanzo R, Corsale AM, Paolini F, Di Simone M, Avellone C, Dieli F, Iacopino DG, Marchiafava S, Maugeri R, Meraviglia S.
CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms.
Oncol Rev. 2026 Jul 2;20:1808229. doi: 10.3389/or.2026.1808229. PMID: 42466093. ˍ

Yang J, Li J, Jin M, Lu Y, Zhang L.
The immunosuppressive tumor microenvironment in glioblastoma.
Front Immunol. 2026 Jul 2;17:1806996. doi: 10.3389/fimmu.2026.1806996. PMID: 42465775. ˍ

Mittelbronn M.
Neurooncology: 2026 update.
Free Neuropathol. 2026 Jul 9;7:17. doi: 10.17879/freeneuropathology-2026-9688. PMID: 42445897. ˍ